Process Validation and Reporting in Hospital Hemovigilance Services

Abstract

Objective: Hemovigilance covers the entire transfusion chain, from the collection of the blood product and its components to the monitoring of adverse reactions. The aim of our study was to perform a process validation for the hemovigilance system of our hospital and to evaluate patients who developed blood transfusion reactions. Method: University of Health Sciences Turkey, Dr. Behçet Uz Child Health and Diseases Training and Research Hospital; among the patients who received blood transfusion between January 2019 and December 2019, 238 patients were identified by systematic sampling method. Blood components used in patients undergoing treatment in different clinics; Examining the physician and nurse observation notes and the data in the hospital information system, whether the transfusion process is appropriate; It was evaluated by hospital hemovigilance coordinator, hemovigilance nurse, pediatric hematologist and pediatric intensive care specialist. Results: Of the 238 randomly selected patients, 122 (51.3%) were male and 116 (48.7%) were determined as female. The median age was 91 (14-180) months. In the evaluation of the transfusion process; Only 1 patient (0.4%) was observed to exceed the optimal transfusion time. No error was detected in other blood transfusion processes. It was observed that 8 (3.3%) of the patients who underwent transfusion had a transfusion reaction. Conclusion: In our study, it was found that there is no significant problem in recognizing, applying and reporting transfusion reactions before and during transfusion applications. In our country, there is no previous study on hemovigilance process validation. Prospective process validations are required.

Keywords

• hemovigilance
• blood transfusion
• process validation
• transfusion reactions